This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

This study has been completed.
Information provided by (Responsible Party):
Søren Dinesen Østergaard, Aarhus University Hospital Identifier:
First received: January 21, 2012
Last updated: October 12, 2015
Last verified: October 2015

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Affective Disorders, Psychotic

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Søren Dinesen Østergaard, Aarhus University Hospital:

Biospecimen Retention:   Samples With DNA
blood samples

Enrollment: 50
Study Start Date: February 2012
Study Completion Date: September 2014
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
inpatients or outpatients at Danish Psychiatric Hospitals fulfilling criteria for unipolar depression with psychotic symptoms.

Inclusion Criteria:

  • Fulfilling ICD-10 criteria DF32.3 or DF33.3
  • At least 18 years old
  • Legally competent
  • Informed consent (oral & written)

Exclusion Criteria:

  • Insufficient Danish Language skills
  • Moderate to severe dementia
  • Abuse of psychoactive substances
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01518049

Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital
Aalborg, Denmark, 9000
Sponsors and Collaborators
Søren Dinesen Østergaard
Principal Investigator: Søren D Østergaard, MD Aahus University Hospital
  More Information

Responsible Party: Søren Dinesen Østergaard, Principal Investigator, Aarhus University Hospital Identifier: NCT01518049     History of Changes
Other Study ID Numbers: N-20110029
Study First Received: January 21, 2012
Last Updated: October 12, 2015

Keywords provided by Søren Dinesen Østergaard, Aarhus University Hospital:
Affective Disorders, Psychotic
Biological Markers

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Mood Disorders
Affective Disorders, Psychotic
Schizophrenia Spectrum and Other Psychotic Disorders processed this record on September 20, 2017